Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | BLM | P54132 | 2/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | DRD1 | P21728 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.50 |
| ▸ | EYA2 | O00167 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8103783 | 1.00 | TDP1 (0.50) | TDP1BLMPMP22KDM4ELMNA | |
| Versetamide SCHEMBL15844631 | 0.98 | TDP1 (0.48) | TDP1BLMPMP22KDM4ELMNA | |
| Versetamide SCHEMBL23202642 | 0.98 | TDP1 (0.48) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL8089255 | 0.98 | TDP1 (0.48) | TDP1BLMPMP22KDM4ELMNA | |
| Versetamide SCHEMBL17848990 | 0.97 | TDP1 (0.47) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL5547592 | 0.91 | BLM (0.50) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL15397125 | 0.90 | TDP1 (0.40) | TDP1BLMPMP22KDM4ELMNA | |
| Versetamide SCHEMBL237265 | 0.84 | KDM4E (0.43) | TDP1KDM4EALOX15TSHRCYP2C19 | |
| SCHEMBL24024217 | 0.84 | BLM (0.47) | TDP1BLMPMP22KDM4ELMNA | |
| SCHEMBL8089127 | 0.84 | BLM (0.47) | TDP1BLMPMP22KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 539 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4590277-A1 | PHARMACEUTICAL COMPOSITIONS | Patel, Reena (IN) | 2025-07-30 | — | — | EP | claimed |
| WO-2024062443-A1 | PHARMACEUTICAL COMPOSITIONS | PATEL REENA (IN) | 2024-03-28 | — | — | WO | claimed |
| US-11110185-B2 | Combination formulation | GE HEALTHCARE AS (NO) | 2021-09-07 | — | — | US | claimed |
| EP-2938325-B1 | DICLOFENAC COMPOSITION | THEMIS MEDICARE LTD (IN) | 2019-04-10 | — | — | EP | claimed |
| US-20180303960-A1 | Combination Formulation | GE HEALTHCARE AS (NO) | 2018-10-25 | — | — | US | claimed |
| EP-3378506-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | Lutonix, Inc. (US) | 2018-09-26 | — | — | EP | claimed |
| US-9289539-B2 | Drug releasing coatings for medical devices | LUTONIX, INC. (US) | 2016-03-22 | — | — | US | claimed |
| EP-2968189-A1 | METHODS FOR PREPARING INJECTABLE PROTEIN MICROPARTICLE SUSPENSIONS | Ansun Biopharma, Inc. (US) | 2016-01-20 | — | — | EP | claimed |
| CN-104857573-A | Drug releasing coating for medical device | LUTONIX INC | 2015-08-26 | — | — | CN | claimed |
| US-20150209489-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX INC (US) | 2015-07-30 | — | — | US | claimed |
| WO-2011113616-A9 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK- COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | KING SAUD UNIVERSITY (SA) | 2011-11-17 | — | — | WO | claimed |
| WO-2011119159-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | WANG LIXIAO (US) | 2011-09-29 | — | — | WO | claimed |
| WO-2011113616-A1 | A NANOPARTICLE COMPRISING A MICELLE FORMED BY AN AMPHIPHILIC BLOCK- COPOLYMER AND ENCAPSULATING A GADOLINIUM COMPLEX | KING SAUD UNIVERSITY (SA) | 2011-09-22 | — | — | WO | claimed |
| US-20100226943-A1 | SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL | UNIVERSITY OF FLORIDA (US) | 2010-09-09 | — | — | US | claimed |
| US-20100209472-A1 | DRUG RELEASING COATINGS FOR MEDICAL DEVICES | LUTONIX, INC. | 2010-08-19 | — | — | US | claimed |
| CN-101330905-A | Freeze-drying process and products obtained thereby | SCIDOSE LLC (US) | 2008-12-24 | — | — | CN | claimed |
| EP-1954244-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | Scidose, Llc (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007061529-A1 | LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY | SCIDOSE LLC. (US) | 2007-05-31 | — | — | WO | claimed |
| US-20070116729-A1 | Lyophilization process and products obtained thereby | SCIDOSE LLC | 2007-05-24 | — | — | US | claimed |
| US-5508388-A | REACTING DIETHYLENETRIAMINEPENTAACETIC ACID WITH ACETIC ANHYDRIDE, REACTING WITH PRIMARY OR SECONDARY AMINE TO FORM COMPLEXING AGENT, REACTING WITH PARAMAGNETIC METAL ION TO FORM COMPLEX, FILTERING, CRYSTALLIZING | MALLINCKRODT MEDICAL, INC. (US) | 1996-04-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11110185-B2 | Combination formulation | SLC10A1, SLC10A2, RXFP2 | TDP1 3864/4885BLM 3032/4885PMP22 715/4885 |
| US-20180303960-A1 | Combination Formulation | SLC10A1, SLC10A2, RXFP2 | TDP1 3864/4885BLM 3032/4885PMP22 715/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.